\documentclass[twocolumn,twoside]{article}
\makeatletter\if@twocolumn\PassOptionsToPackage{switch}{lineno}\else\fi\makeatother

\usepackage{amsfonts,amssymb,amsbsy,latexsym,amsmath,tabulary,graphicx,times,xcolor}

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
% Following additional macros are required to function some 
% functions which are not available in the class used.
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
\usepackage{url,multirow,morefloats,floatflt,cancel,tfrupee}
\makeatletter


\AtBeginDocument{\@ifpackageloaded{textcomp}{}{\usepackage{textcomp}}}
\makeatother
\usepackage{colortbl}
\usepackage{xcolor}
\usepackage{pifont}
\usepackage[nointegrals]{wasysym}
\urlstyle{rm}
\makeatletter

%%%For Table column width calculation.
\def\mcWidth#1{\csname TY@F#1\endcsname+\tabcolsep}

%%Hacking center and right align for table
\def\cAlignHack{\rightskip\@flushglue\leftskip\@flushglue\parindent\z@\parfillskip\z@skip}
\def\rAlignHack{\rightskip\z@skip\leftskip\@flushglue \parindent\z@\parfillskip\z@skip}

%Etal definition in references
\@ifundefined{etal}{\def\etal{\textit{et~al}}}{}


%\if@twocolumn\usepackage{dblfloatfix}\fi
\usepackage{ifxetex}
\ifxetex\else\if@twocolumn\@ifpackageloaded{stfloats}{}{\usepackage{dblfloatfix}}\fi\fi

\AtBeginDocument{
\expandafter\ifx\csname eqalign\endcsname\relax
\def\eqalign#1{\null\vcenter{\def\\{\cr}\openup\jot\m@th
  \ialign{\strut$\displaystyle{##}$\hfil&$\displaystyle{{}##}$\hfil
      \crcr#1\crcr}}\,}
\fi
}

%For fixing hardfail when unicode letters appear inside table with endfloat
\AtBeginDocument{%
  \@ifpackageloaded{endfloat}%
   {\renewcommand\efloat@iwrite[1]{\immediate\expandafter\protected@write\csname efloat@post#1\endcsname{}}}{\newif\ifefloat@tables}%
}%

\def\BreakURLText#1{\@tfor\brk@tempa:=#1\do{\brk@tempa\hskip0pt}}
\let\lt=<
\let\gt=>
\def\processVert{\ifmmode|\else\textbar\fi}
\let\processvert\processVert

\@ifundefined{subparagraph}{
\def\subparagraph{\@startsection{paragraph}{5}{2\parindent}{0ex plus 0.1ex minus 0.1ex}%
{0ex}{\normalfont\small\itshape}}%
}{}

% These are now gobbled, so won't appear in the PDF.
\newcommand\role[1]{\unskip}
\newcommand\aucollab[1]{\unskip}
  
\@ifundefined{tsGraphicsScaleX}{\gdef\tsGraphicsScaleX{1}}{}
\@ifundefined{tsGraphicsScaleY}{\gdef\tsGraphicsScaleY{.9}}{}
% To automatically resize figures to fit inside the text area
\def\checkGraphicsWidth{\ifdim\Gin@nat@width>\linewidth
	\tsGraphicsScaleX\linewidth\else\Gin@nat@width\fi}

\def\checkGraphicsHeight{\ifdim\Gin@nat@height>.9\textheight
	\tsGraphicsScaleY\textheight\else\Gin@nat@height\fi}

\def\fixFloatSize#1{}%\@ifundefined{processdelayedfloats}{\setbox0=\hbox{\includegraphics{#1}}\ifnum\wd0<\columnwidth\relax\renewenvironment{figure*}{\begin{figure}}{\end{figure}}\fi}{}}
\let\ts@includegraphics\includegraphics

\def\inlinegraphic[#1]#2{{\edef\@tempa{#1}\edef\baseline@shift{\ifx\@tempa\@empty0\else#1\fi}\edef\tempZ{\the\numexpr(\numexpr(\baseline@shift*\f@size/100))}\protect\raisebox{\tempZ pt}{\ts@includegraphics{#2}}}}

%\renewcommand{\includegraphics}[1]{\ts@includegraphics[width=\checkGraphicsWidth]{#1}}
\AtBeginDocument{\def\includegraphics{\@ifnextchar[{\ts@includegraphics}{\ts@includegraphics[width=\checkGraphicsWidth,height=\checkGraphicsHeight,keepaspectratio]}}}

\DeclareMathAlphabet{\mathpzc}{OT1}{pzc}{m}{it}

\def\URL#1#2{\@ifundefined{href}{#2}{\href{#1}{#2}}}

%%For url break
\def\UrlOrds{\do\*\do\-\do\~\do\'\do\"\do\-}%
\g@addto@macro{\UrlBreaks}{\UrlOrds}



\edef\fntEncoding{\f@encoding}
\def\EUoneEnc{EU1}
\makeatother
\def\floatpagefraction{0.8} 
\def\dblfloatpagefraction{0.8}
\def\style#1#2{#2}
\def\xxxguillemotleft{\fontencoding{T1}\selectfont\guillemotleft}
\def\xxxguillemotright{\fontencoding{T1}\selectfont\guillemotright}

\newif\ifmultipleabstract\multipleabstractfalse%
\newenvironment{typesetAbstractGroup}{}{}%

%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%

\usepackage[authoryear]{natbib}



\newif\ifnokeywords\nokeywordsfalse

\makeatletter\input{size10-pointfive.clo}\makeatother%
\definecolor{kwdboxcolor}{RGB}{242,242,242}
\usepackage[hidelinks,colorlinks=true,allcolors=blue]{hyperref}
\linespread{1}                 
\def\floatpagefraction{0.8}

\usepackage[paperheight=11.69in,paperwidth=8.26in,top=1in,bottom=1in,left=1in,right=.75in,headsep=24pt]{geometry}

\usepackage{multirow-custom}

\makeatletter

\def\hlinewd#1{%
  \noalign{\ifnum0=`}\fi\hrule \@height #1%
  \futurelet\reserved@a\@xhline}
\def\tbltoprule{\hlinewd{1pt}\\[-14pt]}
\def\tblbottomrule{\noalign{\vspace*{6pt}}\hline\noalign{\vspace*{2pt}}}
\def\tblmidrule{\hline\noalign{\vspace*{2pt}}}



\let\@articleType\@empty
\let\@journalDoi\@empty
\let\@journalVolume\@empty
\let\@journalIssue\@empty
\let\@crossMarkLink\@empty
\let\@receivedDate\@empty
\let\@acceptedDate\@empty
\let\@revisedDate\@empty
\let\@publishedDate\@empty
\let\@copyrightYear\@empty
\let\@firstPage\@empty
\def\articleType#1{\gdef\@articleType{#1}}
\def\journalDoi#1{\gdef\@journalDoi{#1}}
\def\crossMarkLink#1{\gdef\@crossMarkLink{#1}}
\def\receivedDate#1{\gdef\@receivedDate{#1}}
\def\acceptedDate#1{\gdef\@acceptedDate{#1}}
\def\revisedDate#1{\gdef\@revisedDate{#1}}
\def\publishedDate#1{\gdef\@publishedDate{#1}}
\def\copyrightYear#1{\gdef\@copyrightYear{#1}}
\def\journalVolume#1{\gdef\@journalVolume{#1}}
\def\journalIssue#1{\gdef\@journalIssue{#1}}
\def\firstPage#1{\gdef\@firstPage{#1}}
\let\@issuelogo\@empty%
\let\@issuelogoex\@empty%
\def\issuelogo#1{\gdef\@issuelogo{#1}}
\def\issuelogoex#1{\gdef\@issuelogoex{#1}}


\def\author#1{%
  \gdef\@author{%
    \hskip-\dimexpr(\tabcolsep)\hskip5pt%
    \parbox{\dimexpr\textwidth-1pt}%
    {\fontsize{11}{13}\selectfont\raggedright #1}%
  }%
}


\usepackage{pharmascope-abs}
\usepackage{caption}
\usepackage{lastpage}
\usepackage{fancyhdr}
\usepackage[noindentafter,explicit]{titlesec}
\usepackage{fontspec}

\setmainfont[%
BoldFont=cambriab.ttf,%
ItalicFont=CAMBRIAI.TTF,%
BoldItalicFont=CAMBRIAZ.TTF]{Cambria.ttf}
\lefthyphenmin = 3

\def\title#1{%
  \gdef\@title{%
      \vspace*{-40pt}%
       \ifx\@articleType\@empty\else{\fontsize{10}{12}\scshape\selectfont\hspace{8pt}\@articleType\hfill\mbox{}\par\vspace{2pt}}\fi%
       \minipage{\linewidth}
         \hrulefill\\[-0.7pt]%%{\includegraphics[width=75pt,height=50pt]{ijrps_logo.png}}\hfill
         \mbox{~}\hspace{5pt}\parbox{.1\linewidth}{\IfFileExists{images/\@issuelogo.\@issuelogoex}{\includegraphics[width=79pt,height=61pt]{images/\@issuelogo.\@issuelogoex}}{\includegraphics[width=75pt,height=50pt]{ijrps_logo.png}}}\hfill
         \fcolorbox{kwdboxcolor}{kwdboxcolor}{\parbox{.792\linewidth}{%
          \begin{center}\fontsize{17}{17}\selectfont\scshape\vskip-7pt International Journal of Research in Pharmaceutical Sciences\hfill\end{center}%
          \vspace*{-10pt}\hspace*{4pt}{\fontsize{8}{9}\selectfont Published by JK Welfare \& Pharmascope Foundation\hfill  Journal Home Page: \href{www.ijrps.com}{\color{blue}\underline{\smash{www.ijrps.com}}}}\hspace*{4pt}\mbox{}}}%
       \par\vspace*{-1pt}\rule{\linewidth}{1.3pt}%
       \endminipage%
    \par\vspace*{9.2pt}\parbox{.98\linewidth}{\linespread{.9}\raggedright\fontsize{14}{17}\selectfont #1}%
    \vspace*{-8pt}%
  }
}


\setlength{\parindent}{0pt}
\setlength{\parskip}{0.4pc plus 1pt minus 1pt}

\def\abbrvJournalTitle{Int. J. Res. Pharm. Sci.}

\fancypagestyle{headings}{%
  \renewcommand{\headrulewidth}{0pt}%
  \renewcommand{\footrulewidth}{0.3pt}
  \fancyhf{}%
  \fancyhead[R]{%
    \fontsize{9.12}{11}\selectfont\RunningAuthor,\ \abbrvJournalTitle,\ \ifx\@journalVolume\@empty X\else\@journalVolume\fi%
    \ifx\@journalIssue\@empty\else(\@journalIssue)\fi%
    ,\ \ifx\@firstPage\@empty 1\else\@firstPage\fi-\pageref*{LastPage}%
  }%
  \fancyfoot[LO,RE]{\fontsize{9.12}{11}\selectfont\textcopyright\ International Journal of Research in Pharmaceutical Sciences}%
  \fancyfoot[RO,LE]{\fontsize{9.12}{11}\selectfont\thepage}
}\pagestyle{headings}

                                                         
\fancypagestyle{plain}{%
  \renewcommand{\headrulewidth}{0pt}%
  \renewcommand{\footrulewidth}{0.3pt}%
  \fancyhf{}%
  \fancyhead[R]{%
    \fontsize{9.12}{11}\selectfont\RunningAuthor,\ \abbrvJournalTitle,\ \ifx\@journalVolume\@empty X\else\@journalVolume\fi%
    \ifx\@journalIssue\@empty\else(\@journalIssue)\fi%
    ,\ \ifx\@firstPage\@empty 1\else\@firstPage\fi-\pageref*{LastPage}%
  }%
  \fancyfoot[LO,RE]{\fontsize{9.12}{11}\selectfont\textcopyright\ International Journal of Research in Pharmaceutical Sciences}%
  \fancyfoot[RO,LE]{\fontsize{9.12}{11}\selectfont\thepage}
  \ifx\@firstPage\@empty\else\setcounter{page}{\@firstPage}\fi
}


\def\NormalBaseline{\def\baselinestretch{1.1}}
\usepackage{textcase}
\setcounter{secnumdepth}{0}

\titleformat{\section}[block]{\bfseries\boldmath\NormalBaseline\filright\fontsize{10.5}{13}\selectfont}
{\thesection}
{6pt}
{\MakeTextUppercase{#1}}
[]
\titleformat{\subsection}[block]{\bfseries\boldmath\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubsection}
{6pt}
{#1}
[]
\titleformat{\subsubsection}[block]{\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubsubsection}
{6pt}
{#1}
[]
\titleformat{\paragraph}[block]{\NormalBaseline\filright\fontsize{10.5}{10}\selectfont}
{\theparagraph}
{6pt}
{#1}
[]
\titleformat{\subparagraph}[block]{\NormalBaseline\filright\fontsize{10.5}{12}\selectfont}
{\thesubparagraph}
{6pt}
{#1}
[]

\titlespacing{\section}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subsection}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subsubsection}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\paragraph}{0pt}{.5\baselineskip}{.5\baselineskip}  
\titlespacing{\subparagraph}{0pt}{.5\baselineskip}{.5\baselineskip}

\captionsetup[figure]{skip=1.4pt,font=bf,labelsep=colon,justification=raggedright,singlelinecheck=false}
\captionsetup[table]{skip=1.4pt,font=bf,labelsep=colon,justification=raggedright,singlelinecheck=false}

\def\bibyear#1{#1}
%\def\bibjtitle#1{#1}   %%Publisher request
\def\bibauand{}
\setlength\bibsep{3pt}
\setlength\bibhang{8pt}

\makeatother
\date{}


\begin{document}


\def\RunningAuthor{Arun Kumar Dwivedi et al.}
\firstPage{1207}
\articleType{Original article}
\receivedDate{14 Nov 2019}
\acceptedDate{22 Jan 2020}
\revisedDate{20 Jan 2020}
\journalVolume{2020, 11}
\journalIssue{1}
\journalDoi{ijrps.v11i1.1959}
\copyrightYear{2020}
\def\authorCount{3}
\def\affCount{2}

\def\journalTitle{International Journal of Research in Pharmaceutical Sciences}

\title{Observational Study to evaluate the role of Ultrasonography and X-Ray in Urinary Disease}
\author{Amit~Kumar~Singh\textsuperscript{1},  
            Mishra~S.S\textsuperscript{2}, 
            Arun~Kumar~Dwivedi\textsuperscript{*}\textsuperscript{2}~\\[5pt]{\textsuperscript{1}Section of Radiology (Indian Medicine), Sir Sunder Lal Hospital, Banaras Hindu University, Varanasi-221005, Uttar Pradesh, India}~\\{\textsuperscript{2}Department of Shalya Tantra, Faculty of Ayurveda, Institute of Medical Sciences, Banaras Hindu University, Varanasi-221005, Uttar Pradesh, India}}

\begin{abstract}
Urinary diseases are very common in our society which system constitutes kidneys ureters urinary bladder and urethra various abnormalities occur in these organs due to many reasons like infection inflammation metabolic abnormalities neoplastic changes trauma etc. these abnormalities lead to various physical problems ending into death many times the abnormalities of urinary system can be diagnosed by hematological examination urine analysis radiological examination and histopathological examination especially radiological examination provide wide range of diagnosis of disease of urinary system of almost all origin although various radiological technique like X-ray (plain and contrast) Ultrasonography CT scan MRI and many others are available but in present study X-ray (plain and contrast ) and ultrasonography were used for diagnosis of disease of urinary system because of its easy availability and affordability the diseases of urinary system has been described under the name of Mutrakrichha and Mutraghata in ayurveda these two conditions are in fact group of clinical entities in which urination is difficult and retention is present respectively further they are divided into various subtypes these conditions resembles clinically with various types of urinary diseases early diagnosis has been the always advocated by ayurveda by virtue of this prevention and management becomes easy in the present study written informed consent has been taken from all the patients early detection of these conditions facilitates the management otherwise renal failure may complicate the condition.
\end{abstract}\def\keywordstitle{Keywords}

\begin{keywords}X-ray,\newline Ultrasonography,\newline Urinary diseases,\newline Renal failure,\newline Ayurveda
\end{keywords}
\twocolumn[ \maketitle {\printKwdAbsBox}]
\makeatletter{\raggedright\textsuperscript{*}Corresponding Author\par Name:\ Arun~Kumar~Dwivedi~\\ Phone:\ 9161499774~\\  Email:\ drarunbhu@gmail.com
        \par}\vspace*{-11pt}\hrulefill\par{\fontsize{12}{14}\selectfont ISSN: 0975-7538}\par% 
        \textsc{DOI:}\ \href{https://doi.org/10.26452/\@journalDoi}{\textcolor{blue}{\underline{\smash{https://doi.org/10.26452/\@journalDoi}}}}\par%
        \vspace*{-11pt}\hrulefill\\{\fontsize{9.12}{10.12}\selectfont Production and Hosted by}\par{IJRPS |~\href{www.ijrps.com}{www.ijrps.com}}\par%
        \vspace*{-2pt}{\fontsize{9.12}{10.12}\selectfont\textcopyright\ \@copyrightYear\ $|$ All rights reserved.}\par%
        \vspace*{-11pt}\rule{\linewidth}{1.2pt}
        \makeatother
        
    
\section{Introduction}
It is an established fact that urinary disease is showing an increasing incidence all over the world as more \& more cases are being detected these days due to the help of improved diagnostic modalities. According to WHO, urinary tract disease contributes 830000 mortality and 18467000 disability annually means approximately 1.4 \% of total death and 1 \% unsatisfied life because of disease-related to urinary tract. Chronic renal disease also associated with the disease of cerebrovascular or cardiovascular disease and death due to their complication \unskip~\citep{681302:16114679}.  Male and females are both effected equally by renal disease \unskip~\citep{681302:16114680}. More 


\begin{table*}[!htbp]
\caption{\boldmath {Number and percentage patients according to symptoms of diseases} }
\label{tw-56811f6225f0}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.06940000000000001\linewidth-2\tabcolsep}p{\dimexpr.33339999999999996\linewidth-2\tabcolsep}p{\dimexpr.1972\linewidth-2\tabcolsep}p{\dimexpr.19029999999999998\linewidth-2\tabcolsep}p{\dimexpr.20970000000000002\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}S. No. & Symptoms in patients & \multicolumn{2}{p{\dimexpr(.3875\linewidth-2\tabcolsep)}}{\cAlignHack Number of patients and percentage} & Percentage and \\
\rowcolor{kwdboxcolor} &  & \cAlignHack Male Patient & \cAlignHack Female Patient & total number of Patients\\
\tblmidrule 
1. &
  Asymptomatic &
  \cAlignHack 13(13\%) &
  \cAlignHack 10(10\%) &
  \cAlignHack 23\% (23)\\
2. &
  Dysuria &
  \cAlignHack 12(12\%) &
  \cAlignHack 09(9\%) &
  \cAlignHack 21\% (21)\\
3. &
  Pain in right or left lumber \& pelvic region &
  \cAlignHack 20(20\%) &
  \cAlignHack 14(14\%) &
  \cAlignHack 34\%\\
4. &
  Anuria &
  \cAlignHack 12(12\%) &
  \cAlignHack 10(10\%) &
  \cAlignHack 22\%\\
 &
  Total &
  \cAlignHack 57(57\%) &
  \cAlignHack 43(43\%) &
  \cAlignHack 100\%\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}

\begin{table*}[!htbp]
\caption{\boldmath {Diseases wise number and percentage of patients in the study group} }
\label{tw-cbaec459ce06}
\def\arraystretch{1.1}
\ignorespaces 
\centering 
\begin{tabulary}{\linewidth}{p{\dimexpr.0963\linewidth-2\tabcolsep}p{\dimexpr.31208000000000002\linewidth-2\tabcolsep}p{\dimexpr.19022\linewidth-2\tabcolsep}p{\dimexpr.20282\linewidth-2\tabcolsep}p{\dimexpr.19858000000000004\linewidth-2\tabcolsep}}
\tbltoprule \rowcolor{kwdboxcolor}S. No. & Name of urinary disease & \multicolumn{2}{p{\dimexpr(.39304\linewidth-2\tabcolsep)}}{\cAlignHack Sex wise number and percentage of patients} & Total Patients and percentage\\
\rowcolor{kwdboxcolor} &  & \cAlignHack Male Patients & \cAlignHack Female Patients & \\
\tblmidrule 
1. &
  Urethral structure  &
  \cAlignHack 09 (9\%) &
  \cAlignHack 04 (4\%) &
  \cAlignHack 13(13\%)\\
2. &
  Stones &
  \cAlignHack 12(12\%) &
  \cAlignHack 12(12\%) &
  \cAlignHack 24(24\%)\\
3. &
  PUJ obstruction &
  \cAlignHack 06(6\%) &
  \cAlignHack 04(4\%) &
  \cAlignHack 10(10\%)\\
4. &
  Papillary necrosis &
  \cAlignHack 03(3\%) &
  \cAlignHack 02(2\%) &
  \cAlignHack 05(5\%)\\
5. &
  Infection stricture  &
  \cAlignHack 04(4\%) &
  \cAlignHack 02(2\%) &
  \cAlignHack 06(6\%)\\
6. &
  Prostate problems - prostatic hyperplasia \& Prostate Cancer &
  \cAlignHack 20(20\%) &
  \cAlignHack 00(0\%) &
  \cAlignHack 20(20\%)\\
7. &
  Trauma &
  \cAlignHack 02(2\%) &
  \cAlignHack 05(5\%) &
  \cAlignHack 07(7\%)\\
8. &
  Gynaecological cases- Cystocoele, uterine prolapse  &
  \cAlignHack 00(0\%) &
  \cAlignHack 10(10) &
  \cAlignHack 10(10\%)\\
9. &
  Tumour - Renal cell carcinoma  &
  \cAlignHack 02(2\%) &
  \cAlignHack 03(3\%) &
  \cAlignHack 05(5\%)\\
 &
  Total &
  \cAlignHack 58(58\%) &
  \cAlignHack 42(42\%) &
  \cAlignHack 100(100\%)\\
\tblbottomrule 
\end{tabulary}\par 
\end{table*}
than 30 \% of diabetic patients develop diabetic nephropathy \unskip~\citep{681302:16114681}.  Approximately 1.5 million people depend on renal replacement therapy\unskip~\citep{681302:16114682}. With the help of molecular, biochemical activity and gene sequencing technology, urinary tract disease identifies easily. It has a prevalence of 1 in 1000 people and affects more than 10 million people worldwide \unskip~\citep{681302:16114683}. Urinary tract diseases divided into a complicated and uncomplicated example of uncomplicated are cystitis seen more in females \unskip~\citep{681302:16114684}. It contributes 5 to 8 people per 10000 annually \unskip~\citep{681302:16114685}.  Whereas complicated urinary tract, especially in developing countries, are obstructive or nephropathy leads to urinary schistosomiasis \unskip~\citep{681302:16114686}. In an Industrial belt, a common cause of urinary tract disease is renal stone \unskip~\citep{681302:16114687}. Occur more in developing countries affecting 1 in 1000 people annually \unskip~\citep{681302:16114688}. Some symptoms commonly associated with renal stones are decreased urine volume, hypomagnesuria, hyperuricosuria. 

The aggravating factor which increases the chance of occurrence of the disease is oxalate-rich food, metabolic disorder of cysteine result in low protein, low calcium, low water intake play a key role in the development of renal stone. The causes of an increase in stone formation in children are due to the use of cereal food. Patients with the urinary disease are quite common in clinical practice. In Ayurveda the etiology of mutravikara describe in charak chikitsa are tikshna aushada Seva (Taking strong medicine), rukcha anna (dry meal), atimadhyapaan (excessive intake of alcohol), aanupa Mansa Sevan (meat of marshy animals) adhyashana, ativyayama, ati maithuna, prishtayana (rigging ) \unskip~\citep{681302:16114689}. Sushruta and Charaka describe eight types of mutrakricha. Due to this etiology, it vitiated dosha, which effects Basti and causes derangement of mutramarg lead to mutrakricha. Some common causes of urinary disease are like calculi, ureteric stricture, tumor, B.P.H., etc. In this study, we have taken 100 cases which are come for investigation in a section of Radiology (Indian medicine).
    
\section{Materials and Methods}
In this study, we have taken 100 cases that came for investigation in a section of Radiology (Indian medicine). 

\textbf{Inclusion criteria}

Patients having complained of urinary tract symptoms were randomly selected irrespective of age and sex etc.

\textbf{Exclusive criteria}

Patient with uncontrolled diabetic, hypertension, tuberculosis, etc

\textbf{Intravenous Urography}

The intravenous urogram is the classic routine investigation of uroradiology. The main indication of I.V.P is for renal \& ureteric calculi, ureteric fistulas, stricture \& complex urinary tract infection (including tuberculosis) (3). The IVU consist of a series of plain film taken after administration of an intravenous injection of water-soluble iodine-containing contrast medium patient was prepared with a period of 4 hr starvation \& fluid deprivation \& the bowel purged with a strong laxative.

\textbf{Ultrasonography}

Ultrasound used on transmission of a sound wave with a particular frequency. Through body structure \& ultimately, the formation of images on a computer screen through reflected wave formation of images or echogenicity depend on how much ultrasound wave absorb or reflect through tissue (4). 

\textbf{Observation \& Result}

In this study, a total of 100 patients were studied in which there were 57 male \& 43 females, the showing was the predominance of urinary disease in males than females with the male: female ratio 3:2. Out of 100 studied patients, 23\% were asymptomatic. 34\% of patients presented with having symptoms of pain in the abdomen, 22\% were having complaints of anuria and 21\% suffering from dysuria (Table~\ref{tw-56811f6225f0}). In this study, a total of 100 patients were studied either by IVP \& ultrasonography or one of the procedures as required. Out of these 100 patients 24 patients (24\%) has Calculus, 20 Patients (20\%) had prostatic hyperplasia/mass, 13 patients (13\%) had urethral stricture, 10 patients (10\%) had cystocele/uterine prolapse \& 10 patients (10\%) has PUJ obstruction, 07 patient (7\%) had Trauma, 06 patient (6\%) had infection, 5 patient (5\%) has Tumour, 05 patient (5\%) had papillary necrosis (Table~\ref{tw-cbaec459ce06}).
    
\section{Conclusion }
The commonest Obstructive uropathies observed in the present study was calculi (24\%) following by B.P.H. (20\%). The comments mode of presentation of patients was a pain in the right or left lumber \& Pelvic region. Although many advance techniques are also available, the technique used in the study is simple, safe, effective and widely available for diagnosis of urinary disease.
    

\bibliographystyle{pharmascope_apa-custom}

\bibliography{\jobname}
\end{document}
